QT
RVMD icon

Quantbot Technologies’s Revolution Medicines RVMD Stock Holding History

Quantbot Technologies’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
5,724
-643
-10% -$93.9K 0.04% 598
2026
Q1 		$619K Buy
+6,367
New +$643K 0.03% 782
2025
Q1 		– Sell
-4,245
Closed -$186K – 1819
2024
Q4 		$186K Buy
+4,245
New +$214K 0.01% 1066
2022
Q4 		– Sell
-1,000
Closed -$19K – 2050
2022
Q3 		$19K Sell
1,000
-11,412
-92% -$251K ﹤0.01% 1366
2022
Q2 		$241K Sell
12,412
-1,388
-10% -$27K 0.02% 849
2022
Q1 		$352K Buy
13,800
+11,800
+590% +$257K 0.03% 701
2021
Q4 		$50K Buy
+2,000
New +$56.4K ﹤0.01% 1025
2021
Q3 		– Sell
-1,100
Closed -$34K – 1843
2021
Q2 		$34K Buy
+1,100
New +$38.4K ﹤0.01% 1136

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Quantbot Technologies's RVMD Position: Q2 2026 in Review

Quantbot Technologies reduced its Revolution Medicines (RVMD) stake by 10% in Q2 2026, selling an estimated $93.9K and leaving 5,724 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #598.

Quantbot Technologies first reported a position in RVMD in Q2 2021 and has held it in 8 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Quantbot Technologies held 5,724 shares of Revolution Medicines worth $1.07M as of Q2 2026.
  • Quantbot Technologies sold 643 Revolution Medicines shares in Q2 2026, an estimated $93.9K.
  • Revolution Medicines made up 0.04% of Quantbot Technologies's portfolio in Q2 2026, its #598 holding.
  • Quantbot Technologies first reported a position in Revolution Medicines in Q2 2021 and has held it in 8 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.